FIRM-guided rotor ablation followed by conventional PVI resulted in 76.9% of patients with recurrent nonparoxysmal AF remaining free from AF/AT at 12 months.
Cohort (n=58)
Does FIRM-guided rotor ablation combined with conventional PVI improve freedom from AF/AT in patients with recurrent nonparoxysmal AF?
FIRM-guided rotor ablation combined with conventional PVI demonstrates a high rate of freedom from arrhythmia at 12 months in patients with recurrent nonparoxysmal AF who previously failed conventional ablation.
INTRODUCTION: A patient-tailored ablation approach focused on the elimination of both pulmonary vein triggers as well as substrate drivers may result in favorable outcomes in recurrent persistent AF patients. OBJECTIVE: We evaluated the long-term outcomes of rotor ablation combined with conventional pulmonary vein isolation (PVI) in patients with recurrent nonparoxysmal AF. METHODS: Fifty-eight consecutive patients underwent FIRM-guided rotor ablation followed by conventional PVI for the treatment of recurrent nonparoxysmal AF. A software algorithm was used to display rotational activity at rotor sites by creating propagation maps from unipolar electrograms recorded using a 64-electrode basket catheter. These rotor sites were targeted for ablation, followed by conventional PVI. RESULTS: All patients had nonparoxysmal AF (83% longstanding persistent) and a previously failed conventional ablation procedure. Stable rotors were identified in all patients (mean of 3.0 ± 1.6 per patient), with 55.2% having right atrial rotors and 96.6% left atrial rotors, respectively. Complications occurred in 5.2% of patients, none related to the FIRM procedure. The median follow-up was 12 months. At 6 and 12 months of follow-up, 73.2% and 76.9% of patients remained free from AF/AT, respectively. Excluding 2 patients who underwent a successful redo ablation procedure/electrical cardioversion, at 12 months of follow-up, 69.2% were free from any AF/AT and 73.1% were free from AF after a single FIRM-guided ablation procedure. CONCLUSION: A high degree of success was observed in this cohort of primarily longstanding persistent AF patients treated for recurrent AF with FIRM-guided rotor ablation. Prospective randomized controlled trials are needed.
Spitzer et al. (Fri,) conducted a cohort in recurrent nonparoxysmal atrial fibrillation (n=58). FIRM-guided rotor ablation followed by conventional PVI was evaluated on freedom from AF/AT at 12 months. FIRM-guided rotor ablation followed by conventional PVI resulted in 76.9% of patients with recurrent nonparoxysmal AF remaining free from AF/AT at 12 months.